125 related articles for article (PubMed ID: 11244965)
1. [Neuroendocrine differentiation in ovarian mucinous tumors].
Jiang C; Tan Y; Li E
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):130-3. PubMed ID: 11244965
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in ovarian mucinous tumors.
Jiang C; Tan Y; Li E; Zhang D
Chin Med J (Engl); 2000 Jan; 113(1):70-4. PubMed ID: 11775215
[TBL] [Abstract][Full Text] [Related]
3. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical similarities between pancreatic mucinous cystic tumor and ovarian mucinous cystic tumor.
Suzuki Y; Sugiyama M; Abe N; Fujioka Y; Atomi Y
Pancreas; 2008 Jan; 36(1):e40-6. PubMed ID: 18192871
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.
Kim DJ; Lee MH; Park TI; Bae HI
J Korean Med Sci; 2006 Feb; 21(1):81-5. PubMed ID: 16479070
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
Li XS; Sun J; He XL
Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
[TBL] [Abstract][Full Text] [Related]
7. Argyrophilia in ovarian serous tumors. A comparative study in 127 epithelial ovarian tumors.
Lin M; Hanai J; Wada A; Ozaki M; Nasu K; Okamoto S; Matsumoto K
Histol Histopathol; 1991 Oct; 6(4):477-84. PubMed ID: 1804424
[TBL] [Abstract][Full Text] [Related]
8. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis V; Pavlidis N; Agnantis NJ
Histol Histopathol; 2006 Apr; 21(4):341-7. PubMed ID: 16437378
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of Survivin and Smac in ovarian mucinous tumors].
Wang HX; Chen G; Li GL; Jiang YJ
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):387-90. PubMed ID: 21055155
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors.
Yamashita K; Yamoto M; Shikone T; Minami S; Nakano R
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):316-22. PubMed ID: 9988793
[TBL] [Abstract][Full Text] [Related]
12. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases.
de Nictolis M; Montironi R; Tommasoni S; Valli M; Pisani E; Fabris G; Prat J
Int J Gynecol Pathol; 1994 Jan; 13(1):10-21. PubMed ID: 8112952
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
[TBL] [Abstract][Full Text] [Related]
14. [Accuracy of frozen section in diagnosis of ovarian tumors].
Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):601-3, 635. PubMed ID: 8112130
[TBL] [Abstract][Full Text] [Related]
15. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Ronnett BM; Kajdacsy-Balla A; Gilks CB; Merino MJ; Silva E; Werness BA; Young RH
Hum Pathol; 2004 Aug; 35(8):949-60. PubMed ID: 15297962
[TBL] [Abstract][Full Text] [Related]
16. u-PA expression in benign, borderline and malignant ovarian tumors.
Kiziridou AD; Toliou T; Stefanou D; Agnantis N
Anticancer Res; 2002; 22(2A):985-90. PubMed ID: 12014682
[TBL] [Abstract][Full Text] [Related]
17. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
18. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases.
Cuatrecasas M; Villanueva A; Matias-Guiu X; Prat J
Cancer; 1997 Apr; 79(8):1581-6. PubMed ID: 9118042
[TBL] [Abstract][Full Text] [Related]
19. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
Gaggero G; Sola S; Mora M; Fulcheri E
Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
[TBL] [Abstract][Full Text] [Related]
20. Ovarian intestinal-type mucinous borderline tumors: a nomenclature change is long overdue.
Kurman RJ; Ronnett BM
Int J Gynecol Pathol; 2010 Nov; 29(6):552-3; author reply 553-4. PubMed ID: 20881857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
